843 related articles for article (PubMed ID: 6843158)
1. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of myocardial protective effects between GIK solution and St. Thomas solution by use of canine isolated heart-lung preparations].
Ina H; Yasuda I
Nihon Kyobu Geka Gakkai Zasshi; 1989 Nov; 37(11):2318-27. PubMed ID: 2693545
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of the myocardial thiol pool by N-acetylcysteine. An effective means of improving cardioplegic protection.
Menasché P; Grousset C; Gauduel Y; Mouas C; Piwnica A
J Thorac Cardiovasc Surg; 1992 May; 103(5):936-44. PubMed ID: 1569775
[TBL] [Abstract][Full Text] [Related]
4. Failure of blood cardioplegia to protect myocardium at lower temperatures.
Magovern GJ; Flaherty JT; Gott VL; Bulkley BH; Gardner TJ
Circulation; 1982 Aug; 66(2 Pt 2):I60-7. PubMed ID: 6805979
[TBL] [Abstract][Full Text] [Related]
5. Myocardial energetics after thermally graded hyperkalemic crystalloid cardioplegic arrest.
Krukenkamp I; Silverman N; Sorlie D; Pridjian A; Feinberg H; Levitsky S
J Thorac Cardiovasc Surg; 1986 Jul; 92(1):56-62. PubMed ID: 3724227
[TBL] [Abstract][Full Text] [Related]
6. [Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].
Tachibana H
Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):630-40. PubMed ID: 2373897
[TBL] [Abstract][Full Text] [Related]
7. Myocardial recovery after hypothermic arrest: a comparison of oxygenated crystalloid to blood cardioplegia. The role of calcium.
Heitmiller RF; DeBoer LW; Geffin GA; Toal KW; Fallon JT; Drop LJ; Teplick RS; O'Keefe DD; Daggett WM
Circulation; 1985 Sep; 72(3 Pt 2):II241-53. PubMed ID: 4028363
[TBL] [Abstract][Full Text] [Related]
8. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
[TBL] [Abstract][Full Text] [Related]
9. Myocardial protection during prolonged aortic cross-clamping. Comparison of blood and crystalloid cardioplegia.
Catinella FP; Cunningham JN; Spencer FC
J Thorac Cardiovasc Surg; 1984 Sep; 88(3):411-23. PubMed ID: 6471891
[TBL] [Abstract][Full Text] [Related]
10. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
Ledingham SJ; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
[TBL] [Abstract][Full Text] [Related]
11. Effect of the pH of cardioplegic solution on postarrest myocardial preservation.
Nugent WC; Levine FH; Liapis CD; LaRaia PJ; Tsai CH; Buckley MJ
Circulation; 1982 Aug; 66(2 Pt 2):I68-72. PubMed ID: 7083549
[TBL] [Abstract][Full Text] [Related]
12. Effect of small-amplitude electrical activity on myocardial preservation in the cold potassium-arrested heart.
Landymore RW; Marble AE; Trillo A; MacAulay M; Faulkner G; Cameron C
J Thorac Cardiovasc Surg; 1986 May; 91(5):684-9. PubMed ID: 3702477
[TBL] [Abstract][Full Text] [Related]
13. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
[TBL] [Abstract][Full Text] [Related]
14. Effects of antegrade cardioplegic infusion with simultaneously controlled coronary sinus occlusion on preservation of regionally ischemic myocardium after acute coronary artery occlusion and reperfusion.
Sun SC; Raza ST; Tam SK; Laurence R; Cohn LH
J Thorac Cardiovasc Surg; 1988 Oct; 96(4):626-33. PubMed ID: 3172809
[TBL] [Abstract][Full Text] [Related]
15. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
[TBL] [Abstract][Full Text] [Related]
16. Effect of oxygenated crystalloid cardioplegia on the functional and metabolic recovery of the isolated perfused rat heart.
Coetzee A; Kotzé J; Louw J; Lochner A
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):259-69. PubMed ID: 3945093
[TBL] [Abstract][Full Text] [Related]
17. Does lower systemic temperature enhance cardioplegic myocardial protection?
Grover FL; Fewel JG; Ghidoni JJ; Trinkle JK
J Thorac Cardiovasc Surg; 1981 Jan; 81(1):11-20. PubMed ID: 7453211
[TBL] [Abstract][Full Text] [Related]
18. Multidose blood versus crystalloid cardioplegia. Comparison by quantitative assessment of irreversible myocardial injury.
Feindel CM; Tait GA; Wilson GJ; Klement P; MacGregor DC
J Thorac Cardiovasc Surg; 1984 Apr; 87(4):585-95. PubMed ID: 6708578
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
[TBL] [Abstract][Full Text] [Related]
20. Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia.
Kanter KR; Jaffin JH; Ehrlichman RJ; Flaherty JT; Gott VL; Gardner TJ
Circulation; 1981 Aug; 64(2 Pt 2):II75-80. PubMed ID: 7249332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
